FDA-approved clinical study

Have you been diagnosed with aortic regurgitation?

You may be eligible for a clinical trial. Click the link to answer a few simple questions and learn more.

Now enrolling AR patients

ARTIST Trial – new treatment study. Learn more

We’re now enrolling patients with AR to participate in the ARTIST Trial, a research study evaluating a new treatment designed specifically for AR. Learn more

Videos

TAVI on the Next Level: The Trilogy System

Learn more about the Trilogy System and how it is providing a TAVR solution for severe, symptomatic AR.

Nicolas van Miegham, Stephan Baldus, and Eberhard Grube discuss the Trilogy Transcatheter Heart Valve System, and how it is addressing an unmet need in aortic regurgitation management and treatment.